Literature DB >> 33590937

Percutaneous coronary intervention and 30-day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database).

RobertA Sykes1,2, Mohamed O Mohamed3, Chun Shing Kwok3, Mamas A Mamas3, Colin Berry1,2,4.   

Abstract

Percutaneous coronary intervention (PCI) improves anginal chest pain in most, but not all, treated patients. PCI is associated with unplanned readmission for angina and non-specific chest pain within 30-days of index PCI. Patients with an index hospitalization for PCI between January-November in each of the years 2010-2014 were included from the United States Nationwide Readmissions Database. Of 2 723 455 included patients, the 30-day unplanned readmission rate was 7.2% (n = 196 581, 42.3% female). This included 9.8% (n = 19 183) with angina and 11.1% (n = 21 714) with non-specific chest pain. The unplanned readmission group were younger (62.2 vs 65.1 years; P < 0.001), more likely to be females (41.0% vs 34.2%; P < 0.001), from the lowest quartile of household income (32.9% vs 31.2%; P < 0.001), have higher prevalence of cardiovascular risk factors or have index PCI performed for non-acute coronary syndromes (ACS) (OR:3.46, 95%CI 3.39-3.54). Factors associated with angina readmissions included female sex (OR:1.28, 95%CI 1.25-1.32), history of ischemic heart disease (IHD) (OR:3.28, 95%CI 2.95-3.66), coronary artery bypass grafts (OR:1.79, 95%CI 1.72-2.86), anaemia (OR:1.16, 95%CI 1.11-1.21), hypertension (OR:1.13, 95%CI 1.09, 1.17), and dyslipidemia (OR:1.10, 95%CI 1.06-1.14). Non-specific chest pain compared with angina readmissions were younger (mean difference 1.25 years, 95% CI 0.99, 1.50), more likely to be females (RR:1.13, 95%CI 1.10, 1.15) and have undergone PCI for non-ACS (RR:2.17, 95%CI 2.13, 2.21). Indications for PCI other than ACS have a greater likelihood of readmission with angina or non-specific chest pain at 30-days. Readmissions are more common in patients with modifiable risk factors, previous history of IHD and anaemia.
© 2021 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.

Entities:  

Keywords:  acute coronary syndromes; angina; chest pain; chronic coronary syndromes; heart disease; ischemic; outcomes; percutaneous coronary intervention; readmissions

Mesh:

Year:  2021        PMID: 33590937      PMCID: PMC7943906          DOI: 10.1002/clc.23543

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   3.287


  35 in total

Review 1.  Review of early hospitalisation after percutaneous coronary intervention.

Authors:  Chun Shing Kwok; William Hulme; Ivan Olier; Eric Holroyd; Mamas A Mamas
Journal:  Int J Cardiol       Date:  2016-11-09       Impact factor: 4.164

2.  Early Post-Percutaneous Coronary Intervention Chest Pain: A Nationwide Survey on Interventional Cardiologists' Perspective.

Authors:  Yasir Taha; Deepak L Bhatt; Debabrata Mukherjee; Christopher J White; Jennifer M Treece; Emmanouil S Brilakis; Subhash Banerjee; Timir K Paul
Journal:  Cardiovasc Revasc Med       Date:  2020-05-16

3.  Audit of patients with chest pain presenting to an accident and emergency department over a 6-month period.

Authors:  N J Fothergill; M T Hunt; R Touquet
Journal:  Arch Emerg Med       Date:  1993-09

4.  Effect of Gender on Unplanned Readmissions After Percutaneous Coronary Intervention (from the Nationwide Readmissions Database).

Authors:  Chun Shing Kwok; Jessica Potts; Martha Gulati; Mirvat Alasnag; Muhammad Rashid; Ahmad Shoaib; Muhammad Ayyaz Ul Haq; Rodrigo Bagur; Mamas Andreas Mamas
Journal:  Am J Cardiol       Date:  2018-01-10       Impact factor: 2.778

5.  Hospital readmissions reduction program.

Authors:  Colleen K McIlvennan; Zubin J Eapen; Larry A Allen
Journal:  Circulation       Date:  2015-05-19       Impact factor: 29.690

6.  Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.

Authors:  Filippo Crea; Cathleen Noel Bairey Merz; John F Beltrame; Colin Berry; Paolo G Camici; Juan Carlos Kaski; Peter Ong; Carl J Pepine; Udo Sechtem; Hiroaki Shimokawa
Journal:  Eur Heart J       Date:  2019-08-01       Impact factor: 29.983

7.  Nonspecific Chest Pain and 30-Day Unplanned Readmissions in the United States (From the Nationwide Readmission Database).

Authors:  Chun Shing Kwok; Purvi J Parwani; David L Fischman; Ritu Thamman; Jassim Al Suwaidi; Mohamed Mohamed; Josip A Borovac; Yoon K Loke; Evangelos Kontopantelis; David L Brown; Mamas A Mamas
Journal:  Am J Cardiol       Date:  2019-01-25       Impact factor: 2.778

8.  Postprocedure chest pain after coronary stenting: implications on clinical restenosis.

Authors:  Annapoorna S Kini; Paul Lee; Cristina A Mitre; Mary E Duffy; Samin K Sharma
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

9.  Percutaneous coronary intervention and 30-day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database).

Authors:  RobertA Sykes; Mohamed O Mohamed; Chun Shing Kwok; Mamas A Mamas; Colin Berry
Journal:  Clin Cardiol       Date:  2021-02-16       Impact factor: 3.287

10.  Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders.

Authors:  Thomas J Ford; Eric Yii; Novalia Sidik; Richard Good; Paul Rocchiccioli; Margaret McEntegart; Stuart Watkins; Hany Eteiba; Aadil Shaukat; Mitchell Lindsay; Keith Robertson; Stuart Hood; Ross McGeoch; Robert McDade; Peter McCartney; David Corcoran; Damien Collison; Christopher Rush; Bethany Stanley; Alex McConnachie; Naveed Sattar; Rhian M Touyz; Keith G Oldroyd; Colin Berry
Journal:  Circ Cardiovasc Interv       Date:  2019-12-13       Impact factor: 6.546

View more
  1 in total

1.  Percutaneous coronary intervention and 30-day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database).

Authors:  RobertA Sykes; Mohamed O Mohamed; Chun Shing Kwok; Mamas A Mamas; Colin Berry
Journal:  Clin Cardiol       Date:  2021-02-16       Impact factor: 3.287

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.